electrophoretic mobility shift assay (emsa)ams 501795

38
Electrophoretic Mobility Shift Assay (EMSA) Dr. Songyot Anuchapreeda Department of Clinical Microscopy Faculty of Associated Medical Sciences Chiang Mai University

Upload: api-19918078

Post on 18-Nov-2014

146 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Electrophoretic Mobility Shift Assay (EMSA)

Dr. Songyot AnuchapreedaDepartment of Clinical Microscopy

Faculty of Associated Medical SciencesChiang Mai University

Page 2: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 3: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 4: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 5: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 6: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 7: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 8: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 9: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 10: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 11: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 12: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

5% polyacrylamide gel

Page 13: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 14: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 15: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

5’CTAGAGAGGTGCAACGGAAGCCAGAACATTCCTCC

TGGAAATTCAACCTGTTTCGCAGTTTCTCGAGGAATC

AGCATTCAGTCAATCCGGGCCGGGAGCAGTCATCTGT

GGTGAGGCTGATTGGCTGGGCAGGAACAGCGCCGGGG

CGTGGGCTGAGCACAGCCGCTTCGCTCTCTTTGCCAC

AGGAAGCCTGAGCTCATTCGAGTAGCGGCTCTTCCAA

GCTCAAAGAAGCAGAGGCCGC 3’

-198

+43

+1

AP-1 like motif

SP1Y box

SP1 SP1

Page 16: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

5% acrylamide gel (native gel)

10X TBE 2 mL

29:1 acrylamide/bis (W/W)(in 0.5XTBE 100 mL)6.7 mL

(Final = 30%)

Sterile DEPC treated water 31 mL

10% APS 167 L

205

TEMED 23 L

Total 40 m

Page 17: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 18: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795
Page 19: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Phosphorylation reaction (for consensus oligonucleotide)

Consensus oligonucleotide ( 1.75 pmol/L) 2 L

T4 polynucleotide kinase (10X buffer) 1 L

[-32P] ATP (3,000 Ci/mmol at 10 mCi/ mL) 1 L

Nuclease free water 5 L

T4 nucleotide kinase (5-10 U/L) 1 L

Total volume 10 L

Incubate at 37C for 45 min and then stop reaction with 1L of

0.5 M EDTA then add 15 L of DEPC treated water.

Page 20: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Method used in labeling nucleotides probe

End labelingPolymerase-based labelingNick translation of DNA

Page 21: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

ATP

Page 22: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

End-labeling probe DNA

P

P

P

Page 23: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Component for loading sample

Gel shift binding buffer 2 L

Nuclear extract 50 g/ reaction

Labeled probe 1 L

Nuclease free water up to 10 L

Incubate the reactions at room temperature for 10 min, then

added 1 L of labeled probe. Incubate the reaction on ice

for 60 min. Added 1 L of gel loading 10X buffer per

reaction and analyze the products.

Page 24: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Component for loading sample for competitive EMSA

Gel shift binding buffer 2 L

Nuclear extract 50 g/ reaction

Unlabeled oligonucleotide 1 L

Page 25: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Percent incorporation and specific activity

Percent incorporation (%P) = After column (cpm) x 100

Before column (cpm)

Specific radioactivity (SA) = (Ci)(2.2 x 109)(P)

MI + [(1.3 x 103)(P)(Ci/SA)

Ci = Amount of radiolabeled nucleotide in microcuries in the

reaction mixture.

P = Proportion of radiolabeled nucleotide incorporated into

the probe DNA.

MI = Mass of input of the DNA template in ng.

SA = Specific activity of radiolabeled nucleotide in curies per

milimole (Ci/ mmol)

Page 26: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Example: data after -counter are as follow:

Treatments CPM/LBlank

ReferenceBefore Chroma spin columnAfter Chroma spin column

47.859.3

14,586,732.2515,764.3

188,179.4

Page 27: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

1 2 3 4 5 6

Labeled 32P Oligonucleotide

1 = SP1

2 = AP1

3 = TFIID

4 = NFkB

5 = Oct

6 = CREB

Origin

Free probe

KB-V1 nuclear extract

Page 28: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Autoradiography

Gel electrophoresis

Protein binds to unlabelled competitor

No competitor Competitor

DNA binding protein

Free probe

Nuclear protein, 50 mg

Page 29: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Competiters (cold probe)

Page 30: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

P3P4

Cont SP1 AP1 AP2 Oct CREB NFkB TFIID Cont SP1 AP1 AP2 Oct CREB NFkB TFIID

KB-V1 Curcumin treated cells (KB-V1)

Page 31: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

CREB consensus sequenceCold CREB

- +

Cont SP1 AP1 AP2 TFIID NFkB Oct CREB Competitors

Cold probe 50 molars excess

KB-V1 nuclear protein

Page 32: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

1 2 3 4 origin

1 = Verapamil treated cells

(KB-V1).

2 = KB-3-1 (untreated cells)

3 = Curcumin treated cells

(KB-V1).

4 = KB-V1 (untreated cells)

Free probe

Page 33: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

1 2 3 4

P3P4

Origin

1 = KB-V1 (untreated cells)

2 = KB-3-1 (untreated cells)

3 = Curcumin treated cells

(KB-V1).

4 = Verapamil treated cells

(KB-V1).

Free probe

Page 34: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

C 2p B C C Sig Bk

Protein - DNA complex

Origin

NoteC = Control2p = Isopropanol stepB = BisdemethoxycurcuminSig = SigmaBk = Bisdemethoxycurcumin from Kalsec

Page 35: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Autoradiography

Gel electrophoresis

Protein binds to unlabelled competitor

No supershift Supershift

Supershift

Free probe

Nuclear protein, 50 mg

Ab

Supershift

Page 36: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Component for loading sample for Supershift assay

Anti-CREB 2 g

Gel shift binding buffer 2 L

Nuclear extract 50 g/

reaction

Labeled probe 1 L

Nuclease free water up to 10 L

Page 37: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

Origin

Lane 1. AP2 consensus oligonucleotide 5. NF-B consensus oligonucleotide 2. SP1 consensus oligonucleotide 6. OCT consensus oligonucleotide 3. AP1 consensus oligonucleotide 7. CREB consensus oligonucleotide 4. TFIID consensus oligonucleotide

Free probe

1 2 3 4 5 6 7

Page 38: Electrophoretic Mobility Shift Assay (EMSA)AMS 501795

1 2

1 = control

2 = NE+Anti-CREB

Supershift